ruxolitinib for relapsed/refractory or hydroxyurea-intolerant polycythemia vera patients
Published 7 years ago • 246 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
5:13
ruxolitinib for relapsed/refractory or hydroxyurea-intolerant polycythemia vera patients _old
-
8:55
ruxolitinib for relapsed/refractory or hu-intolerant polycythemia vera
-
1:40
understanding the role of ruxolitinib in patients with polycythemia vera
-
6:39
ruxolitinib patient selection in polycythemia vera
-
5:27
relapsed or refractory polycythemia vera
-
1:14
treating polycythemia vera patients refractory to hydroxyurea
-
4:07
phase ii study of ruxolitinib: essential thrombocythemia(et) refractory to/intolerant of hydroxyurea
-
4:43
the role of ruxolitinib in treating polycythemia vera
-
0:52
reveal study: long-term analysis of ruxolitinib in patients with polycythemia vera after hydroxyurea
-
5:43
moving beyond hydroxyurea for polycythemia vera
-
4:35
polycythemia vera: optimizing ruxolitinib’s role
-
2:44
a 45-year old with polycythemia vera not responding to hydroxyurea
-
1:33
the safety and efficacy of ruxolitinib in polycythemia vera
-
21:43
hydroxyurea intolerance/resistance in polycythemia vera
-
3:01
improved understanding of jak2 inhibition in polycythemia vera
-
2:14
long-term 5-year data continues to show response to ruxolitinib in polycythemia vera
-
0:57
moving beyond hydroxyurea in polycythemia vera
-
4:36
treatment for pv: moving beyond hydroxyurea
-
8:19
how do i know if hydroxyurea is not right for me?